Home » Covid, Novavax asks WHO for emergency authorization for the vaccine

Covid, Novavax asks WHO for emergency authorization for the vaccine

by admin

The American Novavax, together with its partner Serum Institute of India, has submitted to the World Health Organization the request to include its anti-Covid vaccine NVX-CoV2373 in the WHO list for emergency use (Eul).

The question follows the request previously made by the companies to the Drugs Controller General of India (DCGI), a note reads, and represents “a significant step to accelerate access” to vaccines “and a more equitable distribution to countries around the world. who are in great need “of immunization products against Sars-CoV-2, he said Stanley C. Erck, President and CEO.

Covid, if we let Delta circulate, the virus will understand how to make (also) the vaccinated sick

by Antonio Cassone


The manager stressed “the value of global collaboration and the need for multiple approaches to help control the ongoing pandemic”. The concession of the EUL by the WHO – it is specified in the note – is “a prerequisite for exports to numerous countries participating in the Covax program”.

NVX-CoV2373 is a protein-based vaccine that contains tiny particles obtained from a lab-made version of the pandemic coronavirus Spike protein. It also contains an adjuvant, a substance that helps strengthen the immune responses induced by the product.

Novavax, a Covid vaccine different from all the ones we have

by Daniele Banfi


.

See also  «Excess risk for cancer in Porto Marghera». The question

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy